Corticosteroid injections for carpal tunnel syndrome in rheumatoid arthritis carry a low 0.6% complication rate, supporting ...

Adults with giant cell arteritis treated with GLP-1 receptor agonists have a decreased risk for major adverse cardiovascular ...

Researchers evaluated the comparative safety of Janus kinase inhibitors vs tumor necrosis factor inhibitors in older adults ...

Survey data show that most academic rheumatologists prescribe opioids for pain management and frequently experience patient ...

Vitamin K helps blood clot. Babies are born with very little of it, and breast milk supplies only small amounts, the US ...

Medicare Part D data presented at ACR Convergence 2026 show a significant reversal in JAK inhibitor prescription growth following the 2021 FDA boxed warning.

A systematic review evaluates tapering and withdrawal strategies for IL-1 and IL-6 inhibitors in systemic juvenile idiopathic arthritis.

Following clinical trial meta-analyses and real-world observational data, the FDA is requiring manufacturers of all GLP-1 receptor agonists to add warnings regarding nonarteritic anterior ischemic ...

Real-world data show baricitinib carries a higher pneumonia risk in patients with rheumatoid arthritis compared with other JAK inhibitors.

Opioid therapy for pain management in idiopathic inflammatory myopathies carries a greater risk for respiratory failure than ...

Tocilizumab was associated with lower 5-year mortality and reduced respiratory failure vs nintedanib in SSc-ILD in a TriNetX ...

Demographic factors and baseline characteristics have the greatest association with treatment persistence and response among ...